Ivan McKee MSP, Minister for Trade, Investment and Innovation, launches plan to 450 delegates at IBioIC Annual Conference Minister for Trade, Investment and Innovation, Ivan McKee MSP, has today (Thursday 31st January) launched an updated National Plan for Industrial Biotechnology (IB), which aims to boost industry growth and innovation while also raising public awareness of IB as a technology which can help deliver a sustainable...
TC BioPharm (TCB), a developer of CAR-T immuno-oncology products, including Gamma Delta T (GDT) cell therapies, today announced it has completed formulation of its first allogeneic GDT cell banks. The T cell banks provide TCB with core technology to develop a deep portfolio of next-generation CAR-T products directed against a wide variety of different cancer types, both hematological and solid tumors. The project was supported...
Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that it has entered into a new agreement with Olaregen Therapeutix, Inc. (“Olaregen”) to manufacture and produce Excellagen®, an advanced FDA 510(k)-cleared wound healing product indicated for the treatment of hard to heal wounds such as diabetic foot ulcers. The Company originally...
Ingenza, a leading industrial biotech company, is pleased to announce that Syngenta is exercising its commercial licensing option for a technology that enables the development of innovative crop protection products. This enabling technology – the result of an initial collaboration between the two companies – was developed using Ingenza’s inABLE® suite of proprietary gene expression and DNA recombination tools. David McElroy, Chief Business Officer and Company...
Concept Life Sciences (“Concept”), the integrated drug discovery and development and analytical services company, today announced the expansion of its regulatory GLP (good laboratory practice) capabilities at the Group’s Dundee and Bradford sites. The MHRA has confirmed the extension of Dundee’s in vitrocapabilities to cover a range of additional assays, and Bradford can now offer a range of integrated GLP regulatory studies to further support pharmaceuticals,...
Dave Scott of Tepnal Pharma Services discusses the success of the life sciences industry and how the Scotsman conference can contribute to this. To date, 2018 has been another great year for our Life Sciences community. Across the spectrum of different disciplines that make up Life Sciences in Scotland, both pure science and applied science companies continue to compete and win on a global platform. The...